# Surgery Partners, Inc.: filings

SGRY · Nasdaq · CIK 1638833 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sgry.md) · [Financials](/companies/sgry/financials.md) · [Filings](/companies/sgry/filings.md) · [Insiders](/companies/sgry/insiders.md)

## Reports and events: 213 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 372, 8-K 141, 144 99, 3 41, 10-Q 33, SC 13G/A 18, SCHEDULE 13G/A 13, UPLOAD 13, DEFA14A 12, 10-K 11, CORRESP 11, DEF 14A 11, SC 13G 10, SC 13D/A 8, 424B5 6, SCHEDULE 13G 6, ARS 4, S-8 4, SCHEDULE 13D/A 3, 424B7 2, 4/A 2, 8-K/A 2, DEF 14C 2, DRS/A 2, DRSLTR 2, EFFECT 2, PRE 14C 2, S-1/A 2, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, FWP 1, NT 10-K 1, S-1 1, S-3 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 09:27 ET | [SCHEDULE 13D/A](/filings/0001193125-26-431228.md) | Ownership report, active investor, amended | 0001193125-26-431228 |
| 2026-10-26 | 09:03 ET | [8-K](/filings/0001104659-26-118643.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-118643 |
| 2026-09-17 | 09:03 ET | [8-K](/filings/0001638833-26-000085.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001638833-26-000085 |
| 2026-08-10 | 16:14 ET | [10-Q](/filings/0001638833-26-000077.md) | Quarterly report, period 2026-06-30 | 0001638833-26-000077 |
| 2026-08-10 | 07:32 ET | [8-K](/filings/0001638833-26-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-26-000074 |
| 2026-07-24 | 09:01 ET | [8-K](/filings/0001638833-26-000069.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-26-000069 |
| 2026-06-05 | 16:50 ET | [8-K](/filings/0001638833-26-000050.md) | 5.07 Shareholder vote results | 0001638833-26-000050 |
| 2026-05-05 | 16:13 ET | [10-Q](/filings/0001638833-26-000046.md) | Quarterly report, period 2026-03-31 | 0001638833-26-000046 |
| 2026-05-05 | 07:31 ET | [8-K](/filings/0001638833-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-26-000044 |
| 2026-04-23 | 16:03 ET | [DEF 14A](/filings/0001638833-26-000039.md) | Proxy statement, period 2026-06-05 | 0001638833-26-000039 |
| 2026-03-02 | 17:11 ET | [10-K](/filings/0001638833-26-000008.md) | Annual report, period 2025-12-31 | 0001638833-26-000008 |
| 2026-03-02 | 16:55 ET | [8-K](/filings/0001638833-26-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-26-000006 |
| 2025-12-16 | 16:01 ET | [8-K](/filings/0001104659-25-121563.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-121563 |
| 2025-12-12 | 18:51 ET | [8-K](/filings/0001104659-25-120386.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120386 |
| 2025-12-11 | 08:36 ET | [8-K](/filings/0001104659-25-120159.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-120159 |
| 2025-11-12 | 17:24 ET | [8-K](/filings/0001638833-25-000166.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001638833-25-000166 |
| 2025-11-10 | 16:05 ET | [10-Q](/filings/0001638833-25-000163.md) | Quarterly report, period 2025-09-30 | 0001638833-25-000163 |
| 2025-11-10 | 07:32 ET | [8-K](/filings/0001638833-25-000159.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000159 |
| 2025-09-16 | 16:04 ET | [8-K](/filings/0001638833-25-000153.md) | 5.02 Departure or appointment of officers or directors | 0001638833-25-000153 |
| 2025-08-13 | 17:18 ET | [8-K](/filings/0001104659-25-077656.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-077656 |
| 2025-08-06 | 17:10 ET | [8-K](/filings/0001638833-25-000138.md) | 5.02 Departure or appointment of officers or directors | 0001638833-25-000138 |
| 2025-08-05 | 16:28 ET | [10-Q](/filings/0001638833-25-000136.md) | Quarterly report, period 2025-06-30 | 0001638833-25-000136 |
| 2025-08-05 | 07:34 ET | [8-K](/filings/0001638833-25-000132.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000132 |
| 2025-06-17 | 08:34 ET | [SCHEDULE 13D/A](/filings/0000950170-25-087071.md) | Ownership report, active investor, amended | 0000950170-25-087071 |
| 2025-06-17 | 08:03 ET | [8-K](/filings/0001638833-25-000117.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-25-000117 |
| 2025-06-06 | 17:23 ET | [8-K](/filings/0001638833-25-000096.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001638833-25-000096 |
| 2025-05-12 | 16:25 ET | [10-Q](/filings/0001638833-25-000092.md) | Quarterly report, period 2025-03-31 | 0001638833-25-000092 |
| 2025-05-12 | 07:33 ET | [8-K](/filings/0001638833-25-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000089 |
| 2025-04-24 | 16:15 ET | [DEF 14A](/filings/0001638833-25-000084.md) | Proxy statement, period 2025-06-06 | 0001638833-25-000084 |
| 2025-03-07 | 21:32 ET | [10-K](/filings/0001638833-25-000053.md) | Annual report, period 2024-12-31 | 0001638833-25-000053 |
| 2025-03-03 | 07:32 ET | [8-K](/filings/0001638833-25-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000031 |
| 2025-01-28 | 15:22 ET | [8-K](/filings/0001104659-25-006658.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-006658 |
| 2025-01-28 | 08:49 ET | [SCHEDULE 13D/A](/filings/0000950170-25-009488.md) | Ownership report, active investor, amended | 0000950170-25-009488 |
| 2025-01-13 | 17:04 ET | [8-K](/filings/0001638833-25-000002.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001638833-25-000002 |
| 2024-11-12 | 16:18 ET | [10-Q](/filings/0001638833-24-000147.md) | Quarterly report, period 2024-09-30 | 0001638833-24-000147 |
| 2024-11-12 | 07:31 ET | [8-K](/filings/0001638833-24-000143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000143 |
| 2024-08-23 | 16:18 ET | [8-K](/filings/0001638833-24-000137.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001638833-24-000137 |
| 2024-08-06 | 16:04 ET | [10-Q](/filings/0001638833-24-000135.md) | Quarterly report, period 2024-06-30 | 0001638833-24-000135 |
| 2024-08-06 | 07:34 ET | [8-K](/filings/0001638833-24-000132.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000132 |
| 2024-06-20 | 16:30 ET | [8-K](/filings/0001104659-24-073419.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-073419 |
| 2024-06-11 | 17:13 ET | [8-K](/filings/0001638833-24-000127.md) | 5.07 Shareholder vote results | 0001638833-24-000127 |
| 2024-05-07 | 16:03 ET | [10-Q](/filings/0001638833-24-000113.md) | Quarterly report, period 2024-03-31 | 0001638833-24-000113 |
| 2024-05-07 | 07:34 ET | [8-K](/filings/0001638833-24-000110.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000110 |
| 2024-04-25 | 17:01 ET | [DEF 14A](/filings/0001638833-24-000106.md) | Proxy statement, period 2024-06-06 | 0001638833-24-000106 |
| 2024-04-10 | 16:49 ET | [8-K](/filings/0001104659-24-045863.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-045863 |
| 2024-03-26 | 15:55 ET | [8-K](/filings/0001638833-24-000081.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001638833-24-000081 |
| 2024-03-26 | 08:25 ET | [8-K](/filings/0001638833-24-000079.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-24-000079 |
| 2024-02-26 | 16:45 ET | [10-K](/filings/0001638833-24-000029.md) | Annual report, period 2023-12-31 | 0001638833-24-000029 |
| 2024-02-26 | 07:31 ET | [8-K](/filings/0001638833-24-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000026 |
| 2024-01-08 | 07:31 ET | [8-K](/filings/0001638833-24-000006.md) | 2.02 Results of operations | 0001638833-24-000006 |

Page 1 of 5. [Older](/companies/sgry/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:34 ET. No prices; not investment advice.